Statera BioPharma Inc (STAB)

[zino]

Received agreement from the FDA to commence the in vivo biocomparability study," continued Yakov Kogan, PhD, MBA, Chief Executive Officer. "Following completion of the in vivo study and discussion of the submitted study results with the FDA, we expect the agency to resume the review of our pre-EUA dossier

http://www.marketwired.com/press-release/cleveland-biolabs-announces-commencement-of-in-vivo-biocomparability-study-2209885.htm